X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (90) 90
humans (87) 87
male (50) 50
female (49) 49
pharmacology & pharmacy (46) 46
adult (40) 40
pharmacokinetics (38) 38
tuberculosis (38) 38
middle aged (36) 36
microbiology (32) 32
infectious diseases (28) 28
adolescent (18) 18
moxifloxacin (18) 18
rifampin (18) 18
drugs (17) 17
pulmonary tuberculosis (17) 17
tuberculosis - drug therapy (17) 17
antitubercular agents - pharmacokinetics (16) 16
drug therapy (16) 16
tuberculosis, pulmonary - drug therapy (16) 16
immunology (15) 15
rifampin - administration & dosage (15) 15
antitubercular agents - therapeutic use (14) 14
drug administration schedule (14) 14
mycobacterium tuberculosis - drug effects (14) 14
pharmacology (14) 14
antitubercular agents - administration & dosage (13) 13
drug interactions (13) 13
rifampicin (13) 13
rifampin - pharmacokinetics (13) 13
treatment outcome (13) 13
aged (12) 12
area under curve (12) 12
hiv (12) 12
research (12) 12
young adult (12) 12
drug monitoring - methods (11) 11
pharmacodynamics (11) 11
plasma (11) 11
resistance (11) 11
antitubercular agents (10) 10
therapeutic drug monitoring (10) 10
antitubercular agents - adverse effects (9) 9
antitubercular agents - pharmacology (9) 9
dose-response relationship, drug (9) 9
drug therapy, combination (9) 9
mycobacterium-tuberculosis (9) 9
netherlands (9) 9
tanzania (9) 9
toxicology (9) 9
analysis (8) 8
antibiotics, antitubercular - pharmacokinetics (8) 8
children (8) 8
drug monitoring (8) 8
infectious disease (8) 8
mycobacterium tuberculosis - isolation & purification (8) 8
plasma-concentrations (8) 8
respiratory system (8) 8
tacrolimus (8) 8
abridged index medicus (7) 7
antituberculosis drugs (7) 7
care and treatment (7) 7
child (7) 7
fluoroquinolones (7) 7
health aspects (7) 7
medical laboratory technology (7) 7
microbial sensitivity tests (7) 7
mycobacterium tuberculosis (7) 7
rifampin - adverse effects (7) 7
anti-hiv agents - blood (6) 6
antibiotics (6) 6
antibiotics, antitubercular - administration & dosage (6) 6
aza compounds - administration & dosage (6) 6
early bactericidal activity (6) 6
ethambutol (6) 6
in-vitro (6) 6
internal medicine (6) 6
multidrug-resistant tuberculosis (6) 6
prospective studies (6) 6
protease inhibitors (6) 6
pyrazinamide (6) 6
quality control (6) 6
quinolines - administration & dosage (6) 6
retrospective studies (6) 6
sensitivity and specificity (6) 6
tuberculosis - microbiology (6) 6
aged, 80 and over (5) 5
aza compounds - pharmacokinetics (5) 5
biochemical research methods (5) 5
chemistry, analytical (5) 5
child, preschool (5) 5
chromatography, high pressure liquid - methods (5) 5
clinical pharmacokinetics (5) 5
dosage and administration (5) 5
drug resistance (5) 5
drug resistance, bacterial (5) 5
ethambutol - pharmacokinetics (5) 5
hiv infections - drug therapy (5) 5
hiv protease inhibitors - blood (5) 5
immunosuppressive agents - pharmacokinetics (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


09/2011
This study aimed at evaluating the sale of antibacterials for systemic use to outpatients in Moshi Municipality, northern Tanzania. Trained pharmacy assistants... 
Defined Daily Dose (DDD) methodology | Tanzania | Antibacterial sale | Anatomic Therapeutic Chemical (ATC) classification
Web Resource
Lancet Infectious Diseases, The, ISSN 1473-3099, 2013, Volume 13, Issue 1, pp. 27 - 35
Summary Background Intensified antibiotic treatment might improve the outcome of tuberculous meningitis. We assessed pharmacokinetics, safety, and survival... 
Infectious Disease | MYCOBACTERIUM-TUBERCULOSIS | ETHAMBUTOL | INFECTIOUS DISEASES | IN-VITRO | PHARMACOKINETICS | LEVOFLOXACIN | PULMONARY TUBERCULOSIS | INFECTION | DRUG-RESISTANCE | CEREBROSPINAL-FLUID | CIPROFLOXACIN | Fluoroquinolones | Aza Compounds - pharmacokinetics | Antitubercular Agents - adverse effects | Rifampin - pharmacokinetics | Antibiotics, Antitubercular - adverse effects | Follow-Up Studies | Humans | Middle Aged | Aza Compounds - adverse effects | Male | Quinolines - administration & dosage | Quinolines - pharmacokinetics | Young Adult | Drug Therapy, Combination - adverse effects | Rifampin - adverse effects | Adult | Female | Rifampin - administration & dosage | Antibiotics, Antitubercular - administration & dosage | Aza Compounds - administration & dosage | Anti-Infective Agents - adverse effects | Antibiotics, Antitubercular - pharmacokinetics | Tuberculosis, Meningeal - drug therapy | Drug Administration Schedule | Drug Therapy, Combination - methods | Anti-Infective Agents - administration & dosage | Antitubercular Agents - pharmacokinetics | Anti-Infective Agents - pharmacokinetics | Adolescent | Antitubercular Agents - administration & dosage | Tuberculosis, Meningeal - metabolism | Quinolines - adverse effects | Indonesia | Tuberculosis | Meningitis | Dosage and administration | Product development | Moxifloxacin | Universities and colleges | Rifampin | Index Medicus
Journal Article
Bulletin of the World Health Organization, ISSN 0042-9686, 2011, Volume 89, Issue 9, pp. 632 - 639
OBJECTIVE: To assess adherence to community-based directly observed treatment (DOT) among Tanzanian tuberculosis patients using the Medication Event Monitoring... 
DISTRICT | TRIALS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | THERAPY | COMMUNITY | SELF-REPORTED ADHERENCE | TANZANIA | MEMS | CLINICAL-PRACTICE | MEDICATION ADHERENCE | CARE | Directly Observed Therapy - methods | Medication Adherence | Pilot Projects | Humans | Middle Aged | Tuberculosis - drug therapy | Tanzania | Adult | Female | Male | Surveys and Questionnaires | Longitudinal Studies | Index Medicus | Research
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 2015, Volume 191, Issue 9, pp. 1058 - 1065
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 2012, Volume 186, Issue 6, pp. 559 - 565
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 09/2019, Volume 54, Issue 3, pp. 371 - 374
Tuberculous meningitis (TBM) is the most severe manifestation of tuberculosis. Pyrazinamide (PZA) is a pivotal antituberculous drug, but its dose has not been... 
Pyrazinamide | Pharmacokinetics | Tuberculous meningitis | Meningitis | Plasma physics | Tuberculosis | Drug therapy | Rifampin | Index Medicus
Journal Article
European Respiratory Journal, ISSN 0903-1936, 01/2015, Volume 46, Issue 1, pp. 268 - 271
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 11/2014, Volume 69, Issue 11, pp. 2988 - 2994
OBJECTIVES: Since 2007 the Dutch Association for Quality Assessment in Therapeutic Drug Monitoring (KKGT) has organized an international interlaboratory... 
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 2015, Volume 70, Issue 5, pp. 1558 - 1566
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 07/2007, Volume 51, Issue 7, pp. 2546 - 2551
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 10/2007, Volume 45, Issue 8, pp. 1001 - 1007
Journal Article
Lancet Diabetes & Endocrinology, The, ISSN 2213-8587, 2014, Volume 2, Issue 4, pp. 270 - 272
Journal Article